Stem cells are an attractive source for cardiac regeneration, and there is growing interest in their use in treating various heart diseases. The goal is to rebuild functional myocardium either by transplanting exogenous stem cells or by activating native stem cells to stimulate self-repair.
Neutrophils, the most common type of granulocyte, constitute 40–70% of all human leukocytes. Approximately 100–200 billion neutrophils are generated daily in humans through hematopoiesis in the bone marrow. Conventional estimates place the circulating half-life of neutrophils at equilibrium at 4–18 hours. A recent study using advanced techniques has established a more accurate half-life of approximately 19 hours, which is still less than a day.
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
